Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

PBD Biotech expands its North American operations

PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
  • January 27, 2022
  • Company, International
  • international, staff
Tom Kellner

Tom, originally a veterinary scientist, has a strong track record in diagnostics and animal health and has long been involved in TB and Johne’s testing. He says it was PBD Biotech’s innovation that attracted him to the role.

Tom says: “I have been involved in TB and Johne’s testing for 15 years of my career. I licensed the AsureQuality skin test tuberculin in the US and was involved with the use of the gamma interferon test (Bovigam, Primagam and Cervigam) and the Johne’s ELISA test Parachek in laboratories worldwide.”

“What I found most interesting about PBD was their unique approach in the testing of MAP and M. bovis.”

“Also, the application of the test in many animal species and utilization for TB testing in humans.”

“I see enormous potential for the use of PBD’s technology and am excited to be a member of the team.”

Actiphage is also being trialled by State labs in the USA and Canada. This work is hugely beneficial in providing supporting evidence for the OIE validation and also in establishing traction in these important markets.

CEO Jane Theaker, based in the UK, says: “We are delighted that Tom has joined the team. He has a wealth of expertise in bovine TB testing and of the challenges faced by the North American markets.”

Tom is based in the Tampa, FL area and works closely together with Bob Lyons, Director of North American operations.

PBD Biotech has a Canadian headquarters in Saskatoon headed up by Luis Martin, which is validating the use of Actiphage for cattle and also other species important to the country’s economy, such as bison, elk and deer.

Share:

Related posts

Loading...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss of production. Now, advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss...
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have been selected to join the first Missouri Agri-Tech Connect Programme this week (23 – 27 February 2020).
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have...
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd Bovine Brucellosis and Tuberculosis Eradication Campaign (BTEC) Forum on 27 and 28 November 2019.
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd...
Colerado cows

Colorado Laboratory trials new Actiphage test to improve bovine TB diagnosis

July 24, 2019
The Animal Health Laboratory within the Colorado Department of Agriculture is assisting in a trial of Actiphage®, a new rapid blood test for bovine Tuberculosis (bTB) that will detect early-stage infection in cattle and other animals.
Colerado cows

Colorado Laboratory trials new Actiphage test to improve bovine TB diagnosis

July 24, 2019
The Animal Health Laboratory within the Colorado Department of Agriculture is assisting in a trial of Actiphage®, a new rapid...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More